VALERIE MITCHELL: Open Payments
NPI 1083194302 · CLAREMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,916 in 159 payments from 19 companies in 2025. Trend: 2023 $2,070 · 2024 $3,201 · 2025 $3,916
Food & beverage: $3,099Travel & lodging: $817
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 83 | $1,555 |
| Enterra Medical, Inc. | 4 | $1,093 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $267 |
| Janssen Biotech, Inc. | 13 | $220 |
| PFIZER INC. | 9 | $177 |
| Lilly USA, LLC | 5 | $106 |
| Ardelyx, Inc. | 6 | $98 |
| Phathom Pharmaceuticals, Inc. | 8 | $95 |
| Gilead Sciences, Inc. | 4 | $70 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
Products named: CREON, RINVOQ, LINZESS, XIFAXAN, TREMFYA, VELSIPITY, MAVYRET, OMVOH.
Industry payments across OK — which companies pay providers there.
